Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3499-3505

  Lewis, Russell E ^a   Kontoyiannis, Dimitrios P ^a   Darouiche, Rabih O ^a   Raad, Issarn I ^a   Prince, Randall A ^a  

^a EAST TEXAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; VORICONAZOLE;

ANIMAL MODEL; ANTIFUNGAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDIASIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COMPARTMENT MODEL; DRUG BLOOD LEVEL; DRUG HALF LIFE; ELECTRON MICROSCOPY; FUNGUS CULTURE; FUNGUS GROWTH; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; AREA UNDER CURVE; CANDIDIASIS; CATHETERIZATION; FLUCONAZOLE; HALF-LIFE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; PYRIMIDINES; TRIAZOLES;

EID: 0036840973     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3499-3505.2002     Document Type: Article

References (27)

1. Baillie, G. S., and L. J. Douglas. 1999. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol. 310:644-656.
2. Baillie, G. S., and L. J. Douglas. 2000. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46:397-403.
3. Bayston, R. 1984. A model of catheter colonization in vitro and its relationship to clinical catheter infections. J. Infect. 9:271-276.
4. Bayston, R., V. Zdroyewski, and S. Barsham. 1988. Use of an in vitro model for studying the eradication of catheter colonization by Staphylococcus epidermidis. J. Infect. 16:141-146.
5. Brooun, A., S. Liu, and K. Lewis. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:640-646.
6. Dato, V. M., and A. S. Dajani. 1990. Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr. Infect. Dis. J. 9:309-314.
7. Edmond, M. B., S. E. Wallace, D. K. McClish, M. A. Pfaller, R. N. Jones, and R. P. Wenzel. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29:239-244.
8. Fridkin, S. K., and W. R. Jarvis. 1996. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9:499-511.
9. Guggenbichler, J. P., D. Berchtold, F. Allerberger, H. Bonatti, J. Hager, W. Pfaller, and M. P. Dierich. 1992. In vitro and in vivo effect of antibiotics on catheters colonized by staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 11:408-415.
10. Hawser, S. P., G. S. Baillie, and L. J. Douglas. 1998. Production of extracellular matrix by Candida albicans biofilms. J. Med. Microbiol. 47:253-256.
11. Lecciones, J. A., J. W. Lee, E. E. Navarro, F. G. Witebsky, D. Marshall, S. M. Steinberg, P. A. Pizzo, and T. J. Walsh. 1992. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin. Infect. Dis. 14:875-883.
12. : Lewis, K. 2001. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45:999-1007.
13. Lewis, R. E., B. C. Lund, M. E. Klepser, E. J. Ernst, and M. A. Pfaller. 1998. Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by with a dynamic in vitro mycotic infection model. Antimicrob. Agents Chemother. 42:1382-1386.
14. Mermel, L. A., B. M. Farr, R. J. Sherertz, Raad, I. I., N. O'Grady, J. S. Harris, and D. E. Craven. 2001. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32:1249-1272.
15. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Ng, T. K., R. C. Chan, F. A. Adeyemi-Doro, S. W. Cheung, and A. F. Cheng. 1996. Rapid high performance liquid chromatographic assay for antifungal agents in human sera. J. Antimicrob. Chemother. 37:465-472.
17. Pearson, M. L. 1996. Guideline for prevention of intravascular device-related infections. I. Intravascular device-related infections: an overview. Hospital Infection Control Practices Advisory Committee. Am. J. Infect. Control 24:262-277.
18. Pearson, R. D., R. T. Steigbigel, H. T. Davis, and S. W. Chapman. 1980. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob. Agents Chemother. 18:699-708.
19. Perea, S., G. J. Pennick, A. Modak, A. W. Fothergill, D. A. Sutton, D. J. Sheehan, and M. G. Rinaldi. 2000. Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. Antimicrob. Agents Chemother. 44:1209-1213.
20. Pfaller, M. A., S. A. Messer, and R. J. Hollis. 1995. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis. Diagn. Microbiol. Infect. Dis. 21:9-14.
21. Raad, I. I., M. F. Sabbagh, K. H. Rand, and R. J. Sherertz. 1992. Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn. Microbiol. Infect. Dis. 15:13-20.
22. Raad, I. 1998. Intravascular-catheter-related infections. Lancet 351:893-898.
23. Ramage, G., K. Vande Walle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
24. Rex, J. H. 1996. Editorial response: catheters and candidemia. Clin. Infect. Dis. 22:467-470.
25. Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, J. Serody, J. E. Edwards, and R. G. Washburn. 1995. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin. Infect. Dis. 21:994-996.
26. Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, and J. E. Edwards. 2000. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin. Infect. Dis. 30:662-678.
27. Wenzel, R. P. 1995. Nosocomial candidemia: risk factors and attributable mortality. Clin. Infect. Dis. 20:1531-1534.